Breast cancer

Updated 20 November 2017

Nipple-sparing mastectomy as good as full surgery

Woman with early stage breast cancer who undergo nipple-saving mastectomies have a similar survival rate to those who undergo full surgery, a new study has found.

Women with early stage breast cancer who chose to preserve the nipple during a mastectomy had similar survival or recurrence rates to women who underwent full breast removal, a new study found.

"Nipple-sparing surgery is oncologically safe in carefully selected women with early stage breast cancer," said Dr. Lucy De La Cruz, a researcher at the University of Miami. She was scheduled to present her findings Thursday at the American Society of Breast Surgeons annual meeting, in Orlando, Fla.

Studies presented at medical meetings are considered preliminary until published in a peer-reviewed journal.

In nipple-sparing surgery, the nipple and the darkened area around the nipple - the areola - are left in place. The breast tissue is taken from underneath the nipple area, according to the American Cancer Society (ACS). Although the nipple area is preserved, blood flow and nerves are affected. That means the nipple usually has little to no feeling, and it's possible the appearance of the nipple may be affected, the ACS noted.

Read: Types of mastectomy

For the new study, De La Cruz pooled the findings of 19 previously published studies, an approach known as a meta-analysis. The studies included more than 5,000 patients.

De La Cruz compared outcomes in women who had nipple-sparing surgery to those who had full breast removal. De La Cruz looked at the two approaches in terms of how often the cancer came back, including how often it recurred at the nipple area, and survival. The nipple-sparing procedure was as safe as a standard full breast removal for all of these measures, the review found.

Six of the studies that compared overall survival between nipple-sparing and non-nipple-sparing surgery even found a 2.5 percent increased chance of survival in women who had the nipple-sparing procedure.

Dr. Irene Wapnir, chief of breast surgery and professor of surgery at Stanford University School of Medicine, said, "This review of the published literature is certainly reassuring about the safety of nipple-sparing mastectomy in patients who are appropriately selected."

Read: A better, less painful way to screen breasts

Not all women are candidates for the procedure

But not all women are candidates for the nipple-sparing surgery, which has been performed in the United States for about 15 years, according to Wapnir. For instance, if the breast cancer is too close to the nipple area, the nipple-sparing surgery may not be possible.

Use of the procedure has increased markedly in the past 10 years, Wapnir said.

However, it's still not a common procedure, with less than 5 percent of U.S. doctors offering the procedure, said Dr. Julie Margenthaler, a surgeon at the Siteman Cancer Center at Washington University in St. Louis.

The nipple-sparing operation is more challenging than a full mastectomy, Margenthaler said. Costs are similar, however, as is insurance reimbursement, she said.

Women need to be warned that nipple sensation will likely be dramatically altered, Wapnir said, especially in response to sexual arousal.

However, the nipple-sparing surgery does give a more natural look after reconstruction than other techniques, she said.

Read more:

What you should know about testing for BRCA cancer gene testing

How to do a breast self exam

Unhealthy insulin levels may boost breast cancer risk

Image: Cancer survivor, after a breast reconstruction / surgery from Shutterstock


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Ask the Expert

Breast cancer expert

Dr Gudgeon qualified in Birmingham, England, in 1968. She has more than 40 years experience in oncology, and in 1994 she founded her practice, Cape Breast Care, where she treats benign and malignant breast cancers. Dr Boeddinghaus obtained her qualification at UCT Medical School in 1994 and her MRCP in London in 1998. She has worked extensively in the field of oncology and has a special interest in the hormonal management of breast cancer. She now works with Dr Gudgeon at Cape Breast Care. Read more.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules